These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


576 related items for PubMed ID: 9422809

  • 1. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P, Nomikos GG, Svensson TH.
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [Abstract] [Full Text] [Related]

  • 2. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.
    Hertel P, Nomikos GG, Schilström B, Arborelius L, Svensson TH.
    Neuropsychopharmacology; 1997 Jul; 17(1):44-55. PubMed ID: 9194049
    [Abstract] [Full Text] [Related]

  • 3. Modulation of central serotonergic neurotransmission by risperidone: underlying mechanism(s) and significance of action.
    Hertel P, Lindblom N, Nomikos GG, Svensson TH.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):815-34. PubMed ID: 9723122
    [Abstract] [Full Text] [Related]

  • 4. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R, Laaris N, Hanoun N, Laporte AM, Le Poul E, Hamon M, Lanfumey L.
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [Abstract] [Full Text] [Related]

  • 5. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
    Haddjeri N, de Montigny C, Blier P.
    Br J Pharmacol; 1997 Mar; 120(5):865-75. PubMed ID: 9138693
    [Abstract] [Full Text] [Related]

  • 6. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
    Lejeune F, Millan MJ.
    Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
    [Abstract] [Full Text] [Related]

  • 7. Receptor-mediated regulation of serotonin output in the rat dorsal raphe nucleus: effects of risperidone.
    Hertel P, Lindblom N, Nomikos GG, Svensson TH.
    Psychopharmacology (Berl); 2001 Jan; 153(3):307-14. PubMed ID: 11271402
    [Abstract] [Full Text] [Related]

  • 8. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
    Wang S, Zhang QJ, Liu J, Wu ZH, Wang T, Gui ZH, Chen L, Wang Y.
    Neuroscience; 2009 Mar 17; 159(2):850-61. PubMed ID: 19174182
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
    Gobert A, Lejeune F, Rivet JM, Audinot V, Newman-Tancredi A, Millan MJ.
    J Pharmacol Exp Ther; 1995 Jun 17; 273(3):1032-46. PubMed ID: 7791073
    [Abstract] [Full Text] [Related]

  • 10. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T, Nakazato A, Nagamine M, Yamaguchi K, Tomisawa K.
    Br J Pharmacol; 1997 Jun 17; 121(3):515-25. PubMed ID: 9179395
    [Abstract] [Full Text] [Related]

  • 11. Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain.
    Haddjeri N, Blier P, de Montigny C.
    J Pharmacol Exp Ther; 1996 May 17; 277(2):861-71. PubMed ID: 8627568
    [Abstract] [Full Text] [Related]

  • 12. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 17; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 13. Neurochemical identification of stereotypic burst-firing neurons in the rat dorsal raphe nucleus using juxtacellular labelling methods.
    Hajós M, Allers KA, Jennings K, Sharp T, Charette G, Sík A, Kocsis B.
    Eur J Neurosci; 2007 Jan 17; 25(1):119-26. PubMed ID: 17241273
    [Abstract] [Full Text] [Related]

  • 14. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function.
    Garratt JC, Crespi F, Mason R, Marsden CA.
    Eur J Pharmacol; 1991 Jan 25; 193(1):87-93. PubMed ID: 1710990
    [Abstract] [Full Text] [Related]

  • 15. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
    Gartside SE, Cole AJ, Williams AP, McQuade R, Judge SJ.
    Eur J Neurosci; 2007 May 25; 25(10):3001-8. PubMed ID: 17509083
    [Abstract] [Full Text] [Related]

  • 16. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F, Hasnat A, Haleem MA, Haleem DJ.
    Acta Pharm; 2010 Jun 25; 60(2):129-40. PubMed ID: 21134850
    [Abstract] [Full Text] [Related]

  • 17. Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex.
    Ohoyama K, Yamamura S, Hamaguchi T, Nakagawa M, Motomura E, Shiroyama T, Tanii H, Okada M.
    Eur J Pharmacol; 2011 Feb 25; 653(1-3):47-57. PubMed ID: 21147094
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP, Jackson DM, Wallsten C, Waszczak BL.
    J Pharmacol Exp Ther; 1999 Feb 25; 288(2):820-6. PubMed ID: 9918594
    [Abstract] [Full Text] [Related]

  • 19. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
    Fornal CA, Martin FJ, Metzler CW, Jacobs BL.
    J Pharmacol Exp Ther; 1999 Oct 25; 291(1):229-38. PubMed ID: 10490909
    [Abstract] [Full Text] [Related]

  • 20. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
    Corradetti R, Le Poul E, Laaris N, Hamon M, Lanfumey L.
    J Pharmacol Exp Ther; 1996 Aug 25; 278(2):679-88. PubMed ID: 8768719
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.